Roche sees slower 2022 sales growth as COVID-19 test demand eases
[ad_1] A box of material for rapid COVID-19 antigenic tests made by Swiss drugmaker Roche is pictured at the University Hospital (CHUV) during the coronavirus disease (COVID-19) outbreak, in Lausanne, Switzerland, November 13, 2020. REUTERS/Denis Balibouse Register now for FREE unlimited access to Reuters.com Register Feb 3 (Reuters) – Swiss drugmaker Roche said sales growth […]
Continue Reading